TimesSquare Capital Management LLC Grows Stock Holdings in Addus HomeCare Co. (NASDAQ:ADUS)

TimesSquare Capital Management LLC lifted its holdings in Addus HomeCare Co. (NASDAQ:ADUS) by 13.0% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 264,088 shares of the company’s stock after acquiring an additional 30,330 shares during the quarter. TimesSquare Capital Management LLC owned 1.63% of Addus HomeCare worth $24,521,000 as of its most recent SEC filing.

Several other institutional investors have also recently made changes to their positions in ADUS. BluePath Capital Management LLC acquired a new stake in Addus HomeCare during the 3rd quarter worth about $31,000. GAMMA Investing LLC acquired a new position in Addus HomeCare in the fourth quarter valued at approximately $34,000. Assetmark Inc. boosted its position in Addus HomeCare by 17.1% in the 3rd quarter. Assetmark Inc. now owns 1,331 shares of the company’s stock worth $113,000 after purchasing an additional 194 shares in the last quarter. DekaBank Deutsche Girozentrale acquired a new stake in shares of Addus HomeCare during the 3rd quarter worth approximately $189,000. Finally, Cetera Trust Company N.A purchased a new position in shares of Addus HomeCare during the 4th quarter valued at approximately $219,000. Hedge funds and other institutional investors own 95.35% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts recently issued reports on ADUS shares. Oppenheimer restated an “outperform” rating and set a $118.00 price target on shares of Addus HomeCare in a research report on Tuesday, March 26th. Royal Bank of Canada restated an “outperform” rating and set a $102.00 target price on shares of Addus HomeCare in a research report on Thursday, February 29th. Bank of America upped their price target on Addus HomeCare from $115.00 to $118.00 and gave the stock a “buy” rating in a report on Tuesday. Stephens reissued an “overweight” rating and issued a $115.00 price objective on shares of Addus HomeCare in a report on Tuesday. Finally, Barclays downgraded Addus HomeCare from an “equal weight” rating to an “underweight” rating and set a $83.00 target price for the company. in a research note on Tuesday, April 23rd. One research analyst has rated the stock with a sell rating and eight have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $106.57.

Addus HomeCare Price Performance

Shares of NASDAQ:ADUS traded up $2.50 during trading on Wednesday, reaching $107.09. The stock had a trading volume of 145,433 shares, compared to its average volume of 124,752. The company has a debt-to-equity ratio of 0.18, a quick ratio of 1.38 and a current ratio of 1.38. Addus HomeCare Co. has a 1-year low of $78.35 and a 1-year high of $107.54. The stock has a market cap of $1.75 billion, a PE ratio of 27.89, a PEG ratio of 1.94 and a beta of 0.96. The business has a fifty day moving average price of $99.03 and a 200-day moving average price of $92.71.

Addus HomeCare (NASDAQ:ADUS) last announced its quarterly earnings data on Monday, May 6th. The company reported $1.21 earnings per share for the quarter, beating analysts’ consensus estimates of $0.97 by $0.24. The company had revenue of $280.70 million for the quarter, compared to analyst estimates of $279.49 million. Addus HomeCare had a return on equity of 9.70% and a net margin of 5.91%. The firm’s revenue for the quarter was up 11.6% on a year-over-year basis. During the same quarter last year, the firm posted $0.84 EPS. On average, equities analysts forecast that Addus HomeCare Co. will post 4.38 earnings per share for the current fiscal year.

Addus HomeCare Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.